[Overview of mood disorders--recent advances in the field of diagnoses, pathophysiology and treatment].
Higuchi
Teruhiko
T
Kohnodai Hospital, National Center of Neurology and Psychiatry, Japan.
D000928:Antidepressive Agents / Q000627:therapeutic use; D002352:Carrier Proteins / Q000235:genetics; D039721:Diagnostic and Statistical Manual of Mental Disorders; D015195:Drug Design; D004565:Electroconvulsive Therapy; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics; D026901:Membrane Transport Proteins; D019964:Mood Disorders / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D009419:Nerve Tissue Proteins; D011110:Polymorphism, Genetic; D011613:Psychotherapy / Q000379:methods; D012701:Serotonin / Q000502:physiology; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000928:Antidepressive Agents; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D012701:Serotonin; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human